FR2687404B1 - Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques. - Google Patents

Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.

Info

Publication number
FR2687404B1
FR2687404B1 FR9201883A FR9201883A FR2687404B1 FR 2687404 B1 FR2687404 B1 FR 2687404B1 FR 9201883 A FR9201883 A FR 9201883A FR 9201883 A FR9201883 A FR 9201883A FR 2687404 B1 FR2687404 B1 FR 2687404B1
Authority
FR
France
Prior art keywords
proteins
related peptides
viral agent
biological applications
immunologically related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9201883A
Other languages
English (en)
Other versions
FR2687404A1 (fr
Inventor
Velibor Krsmanovic
Irena Cosic
Jean-Michel Biquard
Milton T.W. Hearn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9201883A priority Critical patent/FR2687404B1/fr
Application filed by Monash University filed Critical Monash University
Priority to DE0728203T priority patent/DE728203T1/de
Priority to PCT/FR1993/000171 priority patent/WO1993017108A2/fr
Priority to US08/290,736 priority patent/US6294174B1/en
Priority to EP93905412A priority patent/EP0728203A1/fr
Priority to AU36361/93A priority patent/AU682304B2/en
Priority to JP5514589A priority patent/JPH07504409A/ja
Priority to CA002129827A priority patent/CA2129827A1/fr
Publication of FR2687404A1 publication Critical patent/FR2687404A1/fr
Application granted granted Critical
Publication of FR2687404B1 publication Critical patent/FR2687404B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR9201883A 1992-02-19 1992-02-19 Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques. Expired - Fee Related FR2687404B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9201883A FR2687404B1 (fr) 1992-02-19 1992-02-19 Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.
PCT/FR1993/000171 WO1993017108A2 (fr) 1992-02-19 1993-02-19 Peptides analogues de l'image interne d'une proteine virale
US08/290,736 US6294174B1 (en) 1992-02-19 1993-02-19 Peptides immunologically related to known viral protein
EP93905412A EP0728203A1 (fr) 1992-02-19 1993-02-19 Peptides analogues de l'image interne d'une proteine virale
DE0728203T DE728203T1 (de) 1992-02-19 1993-02-19 Zu innerem bild eines virenprotein ahnliche peptide
AU36361/93A AU682304B2 (en) 1992-02-19 1993-02-19 Analogous peptides of the internal image of a viral protein
JP5514589A JPH07504409A (ja) 1992-02-19 1993-02-19 ウィルス因子のタンパク質に免疫学的に近縁するペプチド及びその生物学的利用
CA002129827A CA2129827A1 (fr) 1992-02-19 1993-02-19 Peptides analogues de l'image interne d'une proteine virale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9201883A FR2687404B1 (fr) 1992-02-19 1992-02-19 Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.

Publications (2)

Publication Number Publication Date
FR2687404A1 FR2687404A1 (fr) 1993-08-20
FR2687404B1 true FR2687404B1 (fr) 1994-05-20

Family

ID=9426799

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9201883A Expired - Fee Related FR2687404B1 (fr) 1992-02-19 1992-02-19 Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.

Country Status (8)

Country Link
US (1) US6294174B1 (fr)
EP (1) EP0728203A1 (fr)
JP (1) JPH07504409A (fr)
AU (1) AU682304B2 (fr)
CA (1) CA2129827A1 (fr)
DE (1) DE728203T1 (fr)
FR (1) FR2687404B1 (fr)
WO (1) WO1993017108A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0808846A3 (fr) * 1996-05-22 1998-08-26 Diapharm Limited Peptides réactifs avec des anticorps servant de révélateurs de maladie liée au VIH
GB2318352A (en) * 1996-06-25 1998-04-22 Dejan Markovic Polypeptides mimicking the activity of human erythropoietin
JP2002504023A (ja) * 1997-06-18 2002-02-05 バークシャー・ラボラトリーズ・インコーポレーテッド スペクトル触媒
US8262868B2 (en) * 2001-09-11 2012-09-11 Gr Intellectual Reserve, Llc Spectral chemistry
EP3483261B1 (fr) 2012-04-24 2023-11-29 VCell Therapeutics, Inc. Génération de cellules pluripotentes de novo
CN106459897A (zh) * 2014-03-19 2017-02-22 V 细胞治疗公司 与多能细胞有关的方法
US11839650B2 (en) * 2017-02-02 2023-12-12 Board Of Regents, The University Of Texas System Universal influenza vaccine targeting virus/host recognition
EP4333867A1 (fr) 2021-05-03 2024-03-13 QuantBioRes A/S Peptides inhibant la covid-19

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000517A1 (fr) * 1989-06-30 1991-01-10 Hitachi, Ltd. Procede et appareil de conception assistee de materiau
SE470430B (sv) * 1989-09-18 1994-02-21 Tore Brinck Sätt att utnyttja kvantkemiska metoder vid molekyl-design

Also Published As

Publication number Publication date
CA2129827A1 (fr) 1993-09-02
AU3636193A (en) 1993-09-13
EP0728203A1 (fr) 1996-08-28
AU682304B2 (en) 1997-10-02
US6294174B1 (en) 2001-09-25
WO1993017108A3 (fr) 1993-09-16
FR2687404A1 (fr) 1993-08-20
WO1993017108A2 (fr) 1993-09-02
DE728203T1 (de) 1997-06-05
JPH07504409A (ja) 1995-05-18

Similar Documents

Publication Publication Date Title
MA23065A1 (fr) Microspheres de proteines vegetales modifies hydrolysees et leurs procedes de preparation et d'utilisation.
DK81290A (da) Rekombinante bakterier og malariavaccine indeholdende disse
FR2629863B1 (fr) Accouplement d'echappement flexible
NO972781D0 (no) Aerosolformuleringer av peptider og proteiner
NO943344L (no) MN-gen og -protein
DK47285D0 (da) Renininhiberende peptider og anvendelsen deraf
DE3685626T2 (de) Sequenzierung von peptiden.
NO951401D0 (no) Ikke-numerisk koprosessor
FR2499414B1 (fr) Production d'anticorps proteiniques humains
FR2687404B1 (fr) Peptides immunologiquement apparentes aux proteines d'un agent viral et leurs applications biologiques.
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
DK400287A (da) Rekombinante htlv-iii proteiner og anvendelser deraf
DE69123345T2 (de) Sequenzielle c-termin degradierung von peptiden und proteinen
IT1184796B (it) Iniziatore di prossimita' ad ultrasuoni
FR2617938B1 (fr) Joint d'etancheite a soufflet
FR2481316B1 (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
NO881502L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
DK0456138T3 (da) Peptidamidaser og anvendelse deraf
FI953257A0 (fi) Rekombinanttinen ihmisen prostaspesifinen antigeenRekombinanttinen ihmisen prostaspesifinen antigeeni ja sen käytöt i ja sen käytöt
ITFI920071A1 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
FR2681327B1 (fr) Proteines capables notamment de constituer des facteurs de regulation fonctionnelle de la cellule et leurs applications biologiques.
DE69030316D1 (de) Schrittweiser c-terminaler abbau von peptiden und proteinen
IE872013L (en) "recombinant htlv-iii proteins and uses thereof"
FR2638179B1 (fr) Structures d'abris et d'amenagements
FR2649891B1 (fr) Anticorps monoclonaux diriges contre les proenzymes de la cathepsine b-like et leurs applications biologiques

Legal Events

Date Code Title Description
ST Notification of lapse